News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,766 Results
Type
Article (8016)
Company Profile (140)
Press Release (477609)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166816)
Career Advice (305)
Deals (25753)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238300)
Policy (17922)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33161)
ALS (106)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (276)
Approvals (10397)
Artificial intelligence (326)
ASCO (159)
Autoimmune disease (216)
Automation (29)
Bankruptcy (263)
Best Places to Work (6963)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3715)
Cardiovascular disease (225)
Career advice (246)
Career pathing (1)
CAR-T (177)
CDMO (10)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (35)
Clinical research (47987)
Collaboration (1269)
Commercialization (3)
Compensation (1518)
Complete response letters (34)
COVID-19 (760)
CRISPR (64)
C-suite (787)
Cystic fibrosis (86)
Data (5805)
Denatured (4)
Depression (103)
Dermatology (67)
Diabetes (350)
Diagnostics (4200)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73784)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88058)
Executive appointments (710)
FDA (12448)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (937)
Gene editing (126)
Generative AI (9)
Gene therapy (329)
GLP-1 (294)
Government (955)
Grass and pollen (2)
Guidances (281)
Healthcare (9381)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (950)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (42)
IPO (12401)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (16)
Liver cancer (45)
Longevity (19)
Lung cancer (520)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (551)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8681)
Medtech (8835)
Mergers & acquisitions (14401)
Metabolic disorders (718)
mRNA (60)
Multiple sclerosis (105)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1851)
NextGen: Class of 2026 (3153)
Non-profit (847)
Obesity (227)
Opinion (10)
Ovarian cancer (161)
Pain (176)
Pancreatic cancer (204)
Parkinson's disease (204)
Partnered (12)
Patents (490)
Patient recruitment (523)
Peanut (31)
People (41338)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15502)
Phase 2 (21422)
Phase 3 (14449)
Pipeline (7595)
Policy (18)
Postmarket research (1572)
Preclinical (6550)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (193)
Rare diseases (583)
Real estate (3024)
Recruiting (6)
Regulatory (14910)
Reports (23)
Research institute (585)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (89)
Sponsored (5)
Startups (2022)
Stomach cancer (3)
Supply chain (51)
Vaccines (332)
Venture capital (17)
Weight loss (74)
Women's health (83)
Date
Today (82)
Last 7 days (374)
Last 30 days (1483)
Last 365 days (19044)
2026 (13287)
2025 (19251)
2024 (22988)
2023 (26541)
2022 (34618)
2021 (37199)
2020 (33504)
2019 (23280)
2018 (17470)
2017 (18776)
2016 (17918)
2015 (24284)
2014 (21680)
2013 (18138)
2012 (20222)
2011 (20441)
2010 (20333)
Location
Africa (228)
Alabama (75)
Alaska (2)
Arizona (308)
Arkansas (11)
Asia (17936)
Australia (2106)
California (12260)
Canada (3211)
China (538)
Colorado (490)
Connecticut (423)
Delaware (210)
Europe (24674)
Florida (1838)
Georgia (390)
Hawaii (3)
Idaho (46)
Illinois (717)
India (52)
Indiana (320)
Iowa (16)
Japan (415)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1221)
Massachusetts (8047)
Michigan (311)
Minnesota (568)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (60)
New Jersey (2670)
New Mexico (12)
New York (2875)
North Carolina (1310)
North Dakota (4)
Northern California (6161)
Ohio (287)
Oklahoma (14)
Oregon (16)
Pennsylvania (2288)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5100)
Tennessee (122)
Texas (1989)
United States (39731)
Utah (366)
Vermont (1)
Virginia (156)
Washington D.C. (38)
Washington State (953)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,766 Results for "seaspine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Orthofix Medical Reports Orthofix and SeaSpine Fourth Quarter and Full-Year 2022 Results
The merger of Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) became effective as of January 5, 2023.
March 6, 2023
·
25 min read
Business
Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results
The merger of equals between Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) became effective as of January 5, 2023.
January 9, 2023
·
13 min read
Biotech Beach
SeaSpine to Present at the Stifel 2022 Healthcare Conference
SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that the Company will present at the upcoming Stifel 2022 Healthcare Conference.
November 2, 2022
·
1 min read
Biotech Beach
SeaSpine Announces 100th Placement of 7D FLASH™ Navigation System
SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the placement of its 100th 7D FLASH™ Navigation System globally.
December 27, 2022
·
4 min read
Business
SeaSpine to Report Third Quarter 2022 Financial Results on November 1, 2022
SeaSpine Holdings Corporation today announced that it will release third quarter financial results after the close of trading on Tuesday, November 1, 2022.
October 24, 2022
·
1 min read
Biotech Beach
SeaSpine Announces Full Commercial Launch of the Mariner MIS Wayfinder System
SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the full commercial launch of the Mariner® MIS Wayfinder System.
October 31, 2022
·
4 min read
Business
SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Quarter 2022
SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the third quarter of 2022.
November 1, 2022
·
9 min read
Business
SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Quarter 2022 and Raises Full Year 2022 Revenue Guidance
SeaSpine Holdings Corporation announced preliminary financial results for the third quarter of 2022.
October 11, 2022
·
5 min read
Deals
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company
Orthofix Medical Inc. and SeaSpine Holdings Corporation announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders.
January 4, 2023
·
8 min read
Biotech Beach
SeaSpine® Announces Full Commercial Launch of Explorer® TO Expandable Interbody System
SeaSpine Holdings Corporation announced the full commercial launch of the Explorer® TO Expandable Interbody System.
April 28, 2022
·
4 min read
1 of 48,577
Next
